Memgen, Inc. — Form D/A

Memgen, Inc. of HOUSTON, TX, a company, filed a Form D amendment with the SEC on 2020-07-10. The offering totals $10.0M, of which $575K was reported sold. Industry: Biotechnology.

Offering

Filed: 2020-07-10
Form: D/A
Accession: 0001760644-20-000003
Industry: Biotechnology
Exemptions: 06b
Total offering: $10.0M
Amount sold: $575K
Remaining: $9.4M
Investors: 7
Date of first sale: 2020-05-21
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-368134

Issuer

Name: Memgen, Inc.
CIK: 0001760644
Entity type: Corporation
Jurisdiction: DELAWARE
Address: 12 GREENWAY PLAZA, HOUSTON, TX, 77046
Phone: 8325485651

Officers, directors & promoters (12)

Name	Role	Location
Gregory Brown	Director	Franklin, TN
Gregory Brown	Executive Officer	Franklin, TN
Patricia Bitar	Director	Houston, TX
Mark Cantwell	Director	Houston, TX
Mark Cantwell	Executive Officer	Houston, TX
Christopher Pagano	Director	Houston, TX
Robert Coates	Director	Houston, TX
Robert Coates	Executive Officer	Houston, TX
Steven Whitley	Director	Houston, TX
Casey Logan	Director	Houston, TX
John Poulos	Director	Houston, TX
Kevin Coveney	Executive Officer	Naples, FL

Other filings by this issuer (9)

Filed	Form	Offering	Sold
2024-12-10	D	$10.0M	$950K
2023-06-30	D/A	$10.0M	$625K
2022-11-17	D	$5.0M	$625K
2021-12-14	D/A	$10.0M	$9.8M
2021-12-13	D	$10.0M	$9.8M
2020-07-10	D/A	$10.0M	$575K
2020-06-02	D	$10.0M	$50K
2019-09-23	D	$5.0M	$350K
2018-12-04	D	$1.9M	$715K

More